Annual long term debt:
$86.27M+$41.76M(+93.80%)Summary
- As of today (July 4, 2025), RXRX annual long term debt is $86.27 million, with the most recent change of +$41.76 million (+93.80%) on December 31, 2024.
- During the last 3 years, RXRX annual long term debt has risen by +$76.30 million (+765.14%).
- RXRX annual long term debt is now at all-time high.
Performance
RXRX Long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly long term debt:
$72.47M-$13.80M(-16.00%)Summary
- As of today (July 4, 2025), RXRX quarterly long term debt is $72.47 million, with the most recent change of -$13.80 million (-16.00%) on March 31, 2025.
- Over the past year, RXRX quarterly long term debt has increased by +$27.61 million (+61.56%).
- RXRX quarterly long term debt is now -16.00% below its all-time high of $86.27 million, reached on December 31, 2024.
Performance
RXRX Quarterly long term debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long term debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
RXRX Long term debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +93.8% | +61.6% |
| 3 y3 years | +765.1% | +51.2% |
| 5 y5 years | +452.1% | - |
RXRX Long term debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +765.1% | -16.0% | +62.8% |
| 5 y | 5-year | at high | +765.1% | -16.0% | +1660.7% |
| alltime | all time | at high | +765.1% | -16.0% | +1660.7% |
RXRX Long term debt History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $72.47M(-16.0%) |
| Dec 2024 | $86.27M(+93.8%) | $86.27M(+16.3%) |
| Sep 2024 | - | $74.17M(+1.4%) |
| Jun 2024 | - | $73.16M(+63.1%) |
| Mar 2024 | - | $44.86M(+0.8%) |
| Dec 2023 | $44.52M(-1.0%) | $44.52M(-2.0%) |
| Sep 2023 | - | $45.43M(-3.4%) |
| Jun 2023 | - | $47.01M(-2.0%) |
| Mar 2023 | - | $47.95M(+6.7%) |
| Dec 2022 | $44.96M | $44.96M(-3.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $46.55M(-3.7%) |
| Jun 2022 | - | $48.35M(+0.9%) |
| Mar 2022 | - | $47.93M(+380.6%) |
| Dec 2021 | $9.97M(-29.4%) | $9.97M(+142.3%) |
| Sep 2021 | - | $4.12M(-65.3%) |
| Jun 2021 | - | $11.85M(-8.1%) |
| Mar 2021 | - | $12.89M(-8.7%) |
| Dec 2020 | $14.12M(-9.6%) | - |
| Dec 2020 | - | $14.12M |
| Dec 2019 | $15.63M | - |
FAQ
- What is Recursion Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals annual long term debt year-on-year change?
- What is Recursion Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Recursion Pharmaceuticals?
- What is Recursion Pharmaceuticals quarterly long term debt year-on-year change?
What is Recursion Pharmaceuticals annual long term debt?
The current annual long term debt of RXRX is $86.27M
What is the all time high annual long term debt for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high annual long term debt is $86.27M
What is Recursion Pharmaceuticals annual long term debt year-on-year change?
Over the past year, RXRX annual long term debt has changed by +$41.76M (+93.80%)
What is Recursion Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of RXRX is $72.47M
What is the all time high quarterly long term debt for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high quarterly long term debt is $86.27M
What is Recursion Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, RXRX quarterly long term debt has changed by +$27.61M (+61.56%)